Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001705905-26-000006

Chief Scientific Officer gave up 5,188 shares (to pay taxes)

  • Chief Scientific Officer acquired 5,567 shares (grant or award)
  • Chief Scientific Officer acquired 17,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-30 Exercise or conversion : show line 1 in the form +9,275 104,670 D
2026-01-30 Shares withheld for taxes : show line 2 in the form −2,859 $5.60 $16,010 101,811 D
2026-01-31 Grant or award : show line 3 in the form +5,567 $3.07 $17,091 107,378 D
2026-02-02 Exercise or conversion : show line 4 in the form +7,775 115,153 D
2026-02-02 Shares withheld for taxes : show line 5 in the form −2,329 $5.55 $12,926 112,824 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −9,275 9,275 D
2026-02-02 Exercise or conversion : show line 7 in the form Restricted Stock Units −7,775 0 D
Loading xslF345X05/form4-02032026_040235.xml…